City
Epaper

Indian pharmaceutical exports get reprieve from Trump’s reciprocal tariffs

By IANS | Updated: April 3, 2025 09:16 IST

New York, April 3 Because of the importance of India’s pharmaceuticals to US healthcare, those exports will get ...

Open in App

New York, April 3 Because of the importance of India’s pharmaceuticals to US healthcare, those exports will get a reprieve from President Donald Trump’s reciprocal tariffs, according to the White House.

The US is the largest importer of pharmaceuticals from India, bringing in products in the category worth $8.73 billion during the 2024 fiscal year, according to statistics cited by the India Brand Equity Foundation (IBEF).

IBEF said 31.5 per cent of India’s pharmaceutical exports went to the US.

The White House factsheet issued on Wednesday after Trump’s announcement of 26 per cent reciprocal tariffs on imports from India said that pharmaceuticals were exempt.

Indian drugs, especially the generics, help hold down the costs of the US healthcare system, which is already one of the most expensive in the world.

Previewing the likely outcomes of the tariffs, ING Bank had warned that “in the absence of a deal with India, we think Trump’s tariffs will mostly drive up drug prices for US consumers” because of the wide use of generics for which India is the major supplier.

Given the importance of Indian pharmaceuticals, President Trump has exempted that category even without a deal.

IQVIA, a healthcare data and analytics company, said that four out of ten prescriptions filled in the US in 2022 were from Indian companies.

“Out of the top 10 therapy areas by prescription volume, Indian companies supplied more than half of the prescriptions for five: hypertension, mental health, lipid regulators, nervous system disorders, and antiulcerants”, it said.

IQVIA estimated that by using generics from India, rather than high-priced branded products, the US healthcare system saved $219 billion in 2022 and a total of $1.3 trillion between 2013 and 2022.

These savings dwarf the dollar values of the pharmaceutical imports from India, and 26 per cent tariffs on them would have had a domino effect across the healthcare system, especially Medicare, the government healthcare insurance system for seniors, that is already facing challengee to long-rage viability.

The White House factsheet said that copper, semiconductors, lumber, bullion, energy and certain minerals that are not available in the US are also exempt from the reciprocal tariffs.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

InternationalJapan's Shinmoedake volcano erupts, sending ash plume

Other SportsLabuschagne aims to silence ‘doubters’ in push for Ashes, puts hand up for opener’s slot

NationalIntense thunderstorms likely again in Hyderabad today

NationalChhattisgarh to launch 'Gaudham Yojana', cowherds to get Rs 10,916 per month

InternationalMan in critical condition following shooting in Australia

International Realted Stories

InternationalPakistan: Monsoon rains in Punjab raise death toll to 166, flood warnings issued

MumbaiMumbai Scam: Two Cab Drivers Arrested After Extorting ₹1,300 and $3,500 from Foreign Tourists

InternationalNepal: Gai Jatra observed to commemorate memory of loved ones

InternationalTrump signals support for Netanyahu's Gaza takeover amid global criticism

InternationalWhite House considers inviting Zelensky to Trump-Putin Alaska summit amid ceasefire discussions: Reports